Expert Forum: Bladder Cancer - Episode 6

Expert Forum on Bladder Cancer: Future Innovations

“I have no doubt that within 10 years…what we've been basing our treatment strategies and surveillance strategies of high-grade…papillary disease is still going to be there. But, in reality, we're really going to have a much better idea of individual risk stratification and characteristics of their tumors,” says Sam S. Chang, MD, MBA.

In this video Sam S. Chang, MD, MBA, Chad R. Ritch, MD, MBA, FACS,and Christopher B. Anderson, MD, MPH,predict what innovations in the bladder cancer space will look like in the coming years. Chang is a Patricia and Rodes Hart professor of urology and oncology at the Vanderbilt University Medical Center and chief surgical officer at the Vanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. Ritch is an associate professor of urology and an associate director of UHealth International at the Miller School of Medicine, University of Miami, Florida. Anderson is an assistant professor of urology at Columbia University Irving Medical Center, Columbia University, New York City, New York.